NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 324 filers reported holding NOVAVAX INC in Q2 2022. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,766 | -11.4% | 12,813 | -9.0% | 0.06% | -9.7% |
| Q2 2023 | $104,652 | +157.1% | 14,085 | +139.8% | 0.06% | +181.8% |
| Q1 2023 | $40,700 | -51.3% | 5,873 | -27.8% | 0.02% | -50.0% |
| Q4 2022 | $83,566 | +70.5% | 8,129 | +201.9% | 0.04% | +120.0% |
| Q3 2022 | $49,000 | -64.5% | 2,693 | +0.5% | 0.02% | -60.8% |
| Q2 2022 | $138,000 | +102.9% | 2,679 | +190.9% | 0.05% | +70.0% |
| Q1 2022 | $68,000 | -51.1% | 921 | -5.5% | 0.03% | -42.3% |
| Q4 2021 | $139,000 | -34.7% | 975 | -5.2% | 0.05% | -44.7% |
| Q3 2021 | $213,000 | -7.0% | 1,028 | -4.5% | 0.09% | 0.0% |
| Q2 2021 | $229,000 | -45.2% | 1,077 | -53.3% | 0.09% | -46.9% |
| Q1 2021 | $418,000 | +64.6% | 2,308 | +1.5% | 0.18% | +68.6% |
| Q4 2020 | $254,000 | -65.3% | 2,275 | -66.4% | 0.10% | -72.7% |
| Q3 2020 | $733,000 | +14.4% | 6,766 | -12.0% | 0.38% | +26.3% |
| Q2 2020 | $641,000 | – | 7,692 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |